Niagen is Niagen Bioscience's patented form of nicotinamide riboside (NR), an NAD⁺ precursor, sold to consumers under the Tru Niagen brand as capsules and powder. It is the NR ingredient used in most of the published human research on NR.

Is NR safer or more established than NMN?

On documentation, yes. The Niagen NR chloride ingredient has cleared FDA new-dietary-ingredient notification twice without objection and holds an FDA no-objection response to its GRAS notification. NMN's US status, by contrast, has been contested — excluded from the dietary-supplement definition by the FDA in 2022, then reinstated in letters dated 29 September 2025. On efficacy, neither precursor has demonstrated a clinical benefit.

Should I take Tru Niagen instead of getting an NAD⁺ IV?

The oral precursor is the better-evidenced and far cheaper route. Oral NR reliably raises blood NAD⁺ in controlled studies; intravenous NAD⁺ has no controlled outcome trial at all, and costs many times more per session. Neither route has been shown to change how you age.

Most rigorousUpdated July 2026

Tru Niagen review

The studied precursor

The consumer brand of Niagen Bioscience, selling patented nicotinamide riboside (Niagen) as oral capsules and powder.

Our verdict

If you are going to take an NAD⁺ precursor, Niagen is the most defensible thing to take: it is the NR ingredient with the most published human trial data and the clearest regulatory paper trail, and it sidesteps the regulatory question that has followed NMN. That is a real advantage over unbranded precursors — but it buys you a well-evidenced biomarker change, not a proven benefit to how you age.

Check availability →Oral NR supplement, from ~$44/mo

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.

At a glance

Category: NAD⁺ supplement brand
Access: Oral NR supplement, from ~$44/mo
Updated: July 2026

Popular alternative

Enhance MD

Physician-supervised NAD⁺ under lab-guided oversight

Check Enhance MD availability →

What it is

Tru Niagen is the consumer supplement brand of Niagen Bioscience, formerly ChromaDex. It sells Niagen, the company's patented form of nicotinamide riboside, as oral capsules and powder on a subscription or one-off basis. It is a dietary supplement sold over the counter — there is no clinician, no prescription and no clinical service attached to it.

How it works

Direct-to-consumer retail with a subscription option; you order online and it ships. Nobody reviews your health history, so dosing and any interaction questions are yours to take to your own physician. The upside of the model is that the ingredient itself is the same one used in published trials, so if you want to match a studied dose you can do it precisely — NR trials cluster around 300–1,000 mg/day.

Pricing transparency

The provider card carries an entry subscription figure of roughly $44/mo; confirm the current price, what dose that tier actually supplies, and the subscription and cancellation terms before committing, since cost scales with the daily dose. The comparison worth doing is cost per studied daily dose rather than per capsule, and on that basis a precursor supplement is a fraction of the cost of any clinic-delivered NAD⁺ route.

Branded vs compounded

None — a dietary supplement, not a medication. What genuinely distinguishes Niagen is its documentation: the NR chloride ingredient has been through the FDA's new-dietary-ingredient notification process twice without objection and has an FDA no-objection response to its GRAS notification, and it is the NR form used in the published human work — including a controlled study establishing that oral NR is bioavailable and raises the blood NAD⁺ metabolome dose-dependently, and a randomized placebo-controlled trial in healthy middle-aged and older adults finding chronic NR well-tolerated and effective at elevating NAD⁺. That is a real safety and bioavailability package, and it is more than almost anything else in this category has. It is also exactly where the evidence stops. In that randomized trial the cardiovascular signals were exploratory and suggestive, not confirmed endpoints, and no trial of NR shows it extends healthspan, prevents disease or slows aging. As an NR product it is not affected by the regulatory dispute that has surrounded NMN.

Pros and watch-outs

What we like

Niagen is the NR ingredient with the most published human trial data
Two FDA new-dietary-ingredient notifications without objection, plus GRAS no-objection
As NR, it avoids the regulatory dispute that has surrounded NMN
Capsules and powder, on subscription or one-off
Entry pricing is published, and it is far cheaper than any clinic NAD⁺ route

Watch-outs

No trial shows NR extends healthspan, prevents disease or slows aging
The cardiovascular signals in the main randomized trial were exploratory, not confirmed
A supplement retailer — no clinician, no oversight, no dosing guidance
Cost scales with dose, so matching a trial dose costs more than the entry tier
A single-ingredient product — no NMN option if you want that precursor

Best for

People who want the NAD⁺ precursor with the strongest human trial record and the cleanest regulatory documentation.

Who should look elsewhere

Anyone expecting a demonstrated longevity benefit, wanting NMN specifically, or looking for a clinician-managed protocol.

How Tru Niagen compares

A few alternatives worth a look, depending on what you’re optimizing for.

Renue By Science
Liposomal/sublingual NMN with posted lab testing
See Renue By Science →
Invigor Medical
Prescription at-home NAD⁺ injections via telehealth
See Invigor Medical →
Drip Hydration
At-home / concierge NAD⁺ IV infusions
See Drip Hydration →

Compare all providers side by side →

Theo Lindqvist

Peptides & longevity · Reviewed and last verified July 2026

How we assessed this. This review reflects Aminoscope’s own read of Tru Niagen’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

What is Niagen?: Niagen is Niagen Bioscience's patented form of nicotinamide riboside (NR), an NAD⁺ precursor, sold to consumers under the Tru Niagen brand as capsules and powder. It is the NR ingredient used in most of the published human research on NR.
Is Tru Niagen backed by real human research?: More than most of this category, yes. A controlled human study established that oral NR is bioavailable and raises the blood NAD⁺ metabolome dose-dependently, and a randomized placebo-controlled trial in healthy middle-aged and older adults found chronic NR was well-tolerated and effectively elevated NAD⁺. That evidence is about raising the biomarker and short-term tolerability — not about slowing aging.
Is NR safer or more established than NMN?: On documentation, yes. The Niagen NR chloride ingredient has cleared FDA new-dietary-ingredient notification twice without objection and holds an FDA no-objection response to its GRAS notification. NMN's US status, by contrast, has been contested — excluded from the dietary-supplement definition by the FDA in 2022, then reinstated in letters dated 29 September 2025. On efficacy, neither precursor has demonstrated a clinical benefit.
Should I take Tru Niagen instead of getting an NAD⁺ IV?: The oral precursor is the better-evidenced and far cheaper route. Oral NR reliably raises blood NAD⁺ in controlled studies; intravenous NAD⁺ has no controlled outcome trial at all, and costs many times more per session. Neither route has been shown to change how you age.

Check availability →

Or compare every NAD⁺ provider.